Coronavirus (COVID-19)
Learn more
April 26, 2017
Sponsor: Gynecologic Oncology Group
Number: 264
Eligible patients who enroll in the study will be randomly assigned (by chance) to this phase II trial. Phase II trials: the drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety. This trial studies Paclitaxel and Carboplatin to see how well they work compared with Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in treating patients with sex cord-ovarian stromal tumors (gastrointestinal) that have spread to other places in the body and usually cannot be cured or controlled with treatment (advanced) or has returned (recurrent). Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective in treating sex cord-ovarian stromal tumors.
Who’s eligible:
Available at: The Hospital of Central Connecticut, Hartford Hospital.
Referral Line: 860.972.4700
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.